DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn
HOMESERVICESABOUT DNA BRIDGES, INC.CLIENTSNEWSROOMCONTACT US

Developed Strategies that have raised over $120 million USD in corporate financing

DNA Bridges, Inc. is a leading corporate development firm that leverages seasoned scientific and business talent in the life sciences, device and pharmaceutical industries to bridge science and products.

FROM DISCOVERY TO LAUNCH our team has developed and supported the commercialization of products with combined sales over $10 billion USD. These include Herceptin, Xolair, Activase, Raptiva and Kogenate.

 
 
 


OUR NEWS

July 24-26:  Boston
6th Antibody Engineering & Discovery
The DNA Bridges team member, Dr. Greg Landres will be pre-workshop leader and will give opening remarks on Wednesday, July 25. 
http://antibody-engineering.com/


MORE DNA BRIDGES NEWS

INDUSTRY & CLIENT NEWS